Versatope Therapeutics

About

Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.

Lowell,Massachusetts,United States
1 - 10

Highlights

Details

Last Funding Type: Funding Round
Last Funding Money Raised: $193K
Industries: Biotechnology
Founded date: Jan 1, 2017
Number Of Employee: 1 - 10
Operating Status: Active

Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity. The company develops a bacterial factory nano particle technology and multiple epitopes can be displayed to overcome strain-specific immunity, enabling biotechnology companies to develop a single vaccine to protect against multiple strains of influenza.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$18.39M

Versatope Therapeutics has raised a total of $18.39M in funding over 2 rounds. Their latest funding was raised on Sep 9, 2020 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 9, 2020	Grant	$300K	1	—	—	Detail
Sep 3, 2019	Funding Round	$193K	—	—	—	Detail
Sep 26, 2018	Grant	$17.90M	1	—	—	Detail
May 23, 2017	Non-Equity Assistant	—	1	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

3

Versatope Therapeutics is funded by 3 investors. Massachusetts Life Sciences Center and National Institute of Allergy and Infectious Diseases are the most recent investors.